Patient-derived breast tumor xenografts facilitating personalized cancer therapy
Open Access
- 22 January 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Breast Cancer Research
- Vol. 15 (1), 201
- https://doi.org/10.1186/bcr3355
Abstract
Despite improved detection and reduction of breast cancer-related deaths over the recent decade, breast cancer remains the second leading cause of cancer death for women in the US, with 39,510 women expected to succumb to metastatic disease in 2012 alone (American Cancer Society, Cancer Facts &Figures 2012. Atlanta: American Cancer Society; 2012). Continued efforts in classification of breast cancers based on gene expression profiling and genomic sequencing have revealed an underlying complexity and molecular heterogeneity within the disease that continues to challenge therapeutic interventions. To successfully identify and translate new treatment regimens to the clinic, it is imperative that our preclinical models recapitulate this complexity and heterogeneity. In this review article, we discuss the recent advances in development and classification of patient-derived human breast tumor xenograft models that have the potential to facilitate the next phase of drug discovery for personalized cancer therapy based on the unique driver signaling pathways in breast tumor subtypes.Keywords
This publication has 54 references indexed in Scilit:
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancerBreast Cancer Research and Treatment, 2012
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesNature Medicine, 2011
- Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenograftsBreast Cancer Research and Treatment, 2011
- Local regulation of human breast xenograft modelsJournal of Cellular Physiology, 2010
- Genome remodelling in a basal-like breast cancer metastasis and xenograftNature, 2010
- Dissecting genetic requirements of human breast tumorigenesis in a tissue transgenic model of human breast cancer in miceProceedings of the National Academy of Sciences of the United States of America, 2009
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002